IDEAS home Printed from https://ideas.repec.org/a/plo/pone00/0137993.html
   My bibliography  Save this article

Agent-Based Model Forecasts Aging of the Population of People Who Inject Drugs in Metropolitan Chicago and Changing Prevalence of Hepatitis C Infections

Author

Listed:
  • Alexander Gutfraind
  • Basmattee Boodram
  • Nikhil Prachand
  • Atesmachew Hailegiorgis
  • Harel Dahari
  • Marian E Major

Abstract

People who inject drugs (PWID) are at high risk for blood-borne pathogens transmitted during the sharing of contaminated injection equipment, particularly hepatitis C virus (HCV). HCV prevalence is influenced by a complex interplay of drug-use behaviors, social networks, and geography, as well as the availability of interventions, such as needle exchange programs. To adequately address this complexity in HCV epidemic forecasting, we have developed a computational model, the Agent-based Pathogen Kinetics model (APK). APK simulates the PWID population in metropolitan Chicago, including the social interactions that result in HCV infection. We used multiple empirical data sources on Chicago PWID to build a spatial distribution of an in silico PWID population and modeled networks among the PWID by considering the geography of the city and its suburbs. APK was validated against 2012 empirical data (the latest available) and shown to agree with network and epidemiological surveys to within 1%. For the period 2010–2020, APK forecasts a decline in HCV prevalence of 0.8% per year from 44(±2)% to 36(±5)%, although some sub-populations would continue to have relatively high prevalence, including Non-Hispanic Blacks, 48(±5)%. The rate of decline will be lowest in Non-Hispanic Whites and we find, in a reversal of historical trends, that incidence among non-Hispanic Whites would exceed incidence among Non-Hispanic Blacks (0.66 per 100 per years vs 0.17 per 100 person years). APK also forecasts an increase in PWID mean age from 35(±1) to 40(±2) with a corresponding increase from 59(±2)% to 80(±6)% in the proportion of the population >30 years old. Our studies highlight the importance of analyzing subpopulations in disease predictions, the utility of computer simulation for analyzing demographic and health trends among PWID and serve as a tool for guiding intervention and prevention strategies in Chicago, and other major cities.

Suggested Citation

  • Alexander Gutfraind & Basmattee Boodram & Nikhil Prachand & Atesmachew Hailegiorgis & Harel Dahari & Marian E Major, 2015. "Agent-Based Model Forecasts Aging of the Population of People Who Inject Drugs in Metropolitan Chicago and Changing Prevalence of Hepatitis C Infections," PLOS ONE, Public Library of Science, vol. 10(9), pages 1-23, September.
  • Handle: RePEc:plo:pone00:0137993
    DOI: 10.1371/journal.pone.0137993
    as

    Download full text from publisher

    File URL: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0137993
    Download Restriction: no

    File URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0137993&type=printable
    Download Restriction: no

    File URL: https://libkey.io/10.1371/journal.pone.0137993?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    References listed on IDEAS

    as
    1. Garfein, R.S. & Vlahov, D. & Galai, N. & Doherty, M.C. & Nelson, K.E., 1996. "Viral infections in short-term injection drug users: The prevalence of the hepatitis C, hepatitis B, human immunodeficiency, and human T-lymphotropic viruses," American Journal of Public Health, American Public Health Association, vol. 86(5), pages 655-661.
    Full references (including those not matched with items on IDEAS)

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Basmattee Boodram & Mary Ellen Mackesy-Amiti & Aditya Khanna & Bryan Brickman & Harel Dahari & Jonathan Ozik, 2022. "People who inject drugs in metropolitan Chicago: A meta-analysis of data from 1997-2017 to inform interventions and computational modeling toward hepatitis C microelimination," PLOS ONE, Public Library of Science, vol. 17(1), pages 1-17, January.
    2. Zsifkovits, Martin & Zsifkovits, Johannes & Pickl, Stefan W., 2016. "Simulating healthcare quality innovation based on a novel medical treatment: The case of Hepatitis-C in Europe," Technological Forecasting and Social Change, Elsevier, vol. 113(PB), pages 454-459.

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Lelutiu-Weinberger, Corina & Pouget, Enrique R. & Des Jarlais, Don D.C. & Cooper, Hannah L. & Scheinmann, Roberta & Stern, Rebecca & Strauss, Shiela M. & Hagan, Holly, 2009. "A meta-analysis of the hepatitis C virus distribution in diverse racial/ethnic drug injector groups," Social Science & Medicine, Elsevier, vol. 68(3), pages 579-590, February.
    2. Montoya, Isaac D. & Atkinson, John S. & Lichtiger, Benjamin & Whitsett, Donna D., 2003. "Prevalence of hepatitis C in a drug using and non-using welfare population," Health Policy, Elsevier, vol. 64(2), pages 221-228, May.
    3. Harold A. Pollack, 2001. "Can We Protect Drug Users from Hepatitis C?," Journal of Policy Analysis and Management, John Wiley & Sons, Ltd., vol. 20(2), pages 358-364.
    4. Harold A. Pollack, 2001. "Cost-effectiveness of Harm Reduction in Preventing Hepatitis C among Injection Drug Users," Medical Decision Making, , vol. 21(5), pages 357-367, October.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:plo:pone00:0137993. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: plosone (email available below). General contact details of provider: https://journals.plos.org/plosone/ .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.